< Terug naar vorige pagina
Octrooi
Means and methods for treatment of early-onset parkinson's disease
This application relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular, the disclosure describes that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular, the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
Octrooi-publicatienummer: US11202795
Jaar aanvraag: 2015
Jaar toekenning: 2021
Jaar van publicatie: 2021
Status: Toegewezen
URI: link to Espacenet
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven